ReviewThe oncologist2019

Retrospect and Prospect for Lung Cancer in China: Clinical Advances of Immune Checkpoint Inhibitors.

Shun Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.